Reduction in reintegration stress among post-9/11 Veterans in a clinical trial for trauma-related guilt

Abstract: Reintegration stress is commonly reported by returning Veterans with post-trauma distress and associated with mental health and functioning difficulties. Interventions are needed to reduce reintegration stress and provide a pathway to improve Veterans' connections with their families, friends, and communities. The present study compared the effectiveness of Trauma Informed Guilt Reduction Therapy (TrIGR) and Supportive Care Therapy (SCT) in reducing reintegration stress, assessed by the Military to Civilian Questionnaire (M2C-Q) at post-treatment and 3- and 6-month follow-up. Data were derived from a randomized controlled trial treating U.S. military Veterans endorsing trauma-related guilt stemming from an event that occurred during deployment to the recent conflicts in Iraq and Afghanistan (N = 145). Intent to treat analyses using mixed models indicated a significant treatment * time interaction (p = .004) whereby patients randomized to TrIGR reported significantly lower reintegration stress compared to those in SCT by the 6-month follow-up. Between-condition effect sizes were d = 0.11 at post-treatment and d = 0.37 and d = 0.57 at 3- and 6-month follow-up assessments, respectively. Targeting trauma-related guilt may be an effective pathway to help facilitate the process of reintegration to civilian life for some Veterans.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.